Zippie Voyage, early intervention stroller - Product Usage: is manually operated by a caregiver f...
FDA Device Recall #Z-2158-2021 — Class II — July 8, 2021
Recall Summary
| Recall Number | Z-2158-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 8, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Sunrise Medical (US) LLC |
| Location | Fresno, CA |
| Product Type | Devices |
| Quantity | 4,741 device |
Product Description
Zippie Voyage, early intervention stroller - Product Usage: is manually operated by a caregiver for purposes of assisting a disabled person while providing supportive elements for assisted transportation and seating for a child or small adult not to exceed 75 pounds.
Reason for Recall
The seating system unexpectedly detached, which resulted in the seating system falling to the ground, causing injury.
Distribution Pattern
Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The countries of United Kingdom, Germany, France, Canada, Italy, Netherlands, Poland, Czech Republic, Australia, Hong Kong, Japan, Qatar, Norway, United Arab Emirates, China, Saudi Arabia, Sweden, Switzerland, Spain, Indonesia, India, Singapore, Bahrain and Israel.
Lot / Code Information
Model Numbers: EIZ14; Serial Numbers: ZV-001340 through ZV-006153
Other Recalls from Sunrise Medical (US) LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2157-2021 | Class II | Zippie Voyage, early intervention stroller - Pr... | Jul 8, 2021 |
| Z-1947-2020 | Class II | Quickie/Zippie powered wheelchair. Q700M wheelc... | Feb 13, 2020 |
| Z-2290-2016 | Class II | Quickie Q7 wheelchair. Model EIR4 Physical M... | Jul 1, 2016 |
| Z-2466-2015 | Class II | Zippie IRIS Wheelchair. model EIZ5A in combinat... | Jul 27, 2015 |
| Z-2467-2015 | Class II | Quickie IRIS Wheelchair. model EIZ4-2 in combin... | Jul 27, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.